Article

KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer

eLife · 2017 · Elsa B Krall, author Belinda Wang, author Diana M Munoz, author Nina Ilic, author Srivatsan Raghavan, author Matthew J Niederst, author Kristine Yu, author David A Ruddy, author Andrew J Aguirre, author Jong Wook Kim, author Amanda J Redig, author Justin F Gainor, author Juliet A Williams, author John M Asara, author John G Doench, author Pasi A Janne, author Alice T Shaw, author Robert E McDonald III, author Jeffrey A Engelman, author Frank Stegmeier, author Michael R Schlabach, author William C Hahn, author

Key facts

Title KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer
First author Elsa B Krall, author Belinda Wang, author Diana M Munoz, author Nina Ilic, author Srivatsan Raghavan, author Matthew J Niederst, author Kristine Yu, author David A Ruddy, author Andrew J Aguirre, author Jong Wook Kim, author Amanda J Redig, author Justin F Gainor, author Juliet A Williams, author John M Asara, author John G Doench, author Pasi A Janne, author Alice T Shaw, author Robert E McDonald III, author Jeffrey A Engelman, author Frank Stegmeier, author Michael R Schlabach, author William C Hahn, author
Journal eLife
Published Feb 1, 2017
DOI 10.7554/eLife.18970
Product codes mentioned JJH, PFT

At a glance

  • None FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature